23andMe Is Going Public Via a SPAC. Here’s What You Need to Know

Would you want to know if you were at high risk of developing a rare disease? What about knowing whether you’re hereditarily predisposed to enjoying chocolate? With the power of DNA sequencing technology, all it takes is spitting in a tube to answer these (not at all) equally impRead MoreMarketsMarkets Feed